source: WorldVistAEHR/trunk/r/ONCOLOGY-ONC/ONCSSF6.m@ 1259

Last change on this file since 1259 was 613, checked in by George Lilly, 15 years ago

initial load of WorldVistAEHR
File size: 4.9 KB
Line 
1ONCSSF6 ;Hines OIFO/GWB - SITE-SPECIFIC FACTOR 6 (165.5,44.6) ;11/20/03
2 ;;2.11;ONCOLOGY;**40**;Mar 07, 1995
3 ;
4 ;SITE-SPECIFIC FACTOR 6 (165.5,44.6)
5SSF6IT ;INPUT TRANSFORM
6 ;
7 S PS=$P($G(^ONCO(165.5,D0,2)),U,1)
8 I PS="" K X W " No PRIMARY SITE defined for this primary" Q
9 S MO=$$HIST^ONCFUNC(D0)
10 ;
11 S SSFIEN=$S($D(^ONCO(164.52,"C",PS_"-6")):$O(^ONCO(164.52,"C",PS_"-6",0)),1:1)
12 ;
13 ;Malignant Melanoma of Skin, Vulva, Penis, Scrotum
14 I $$MELANOMA^ONCOU55(D0) D
15 .S MELIEN=$O(^ONCO(164.52,"B","LDH",0))
16 .I $E(PS,3,4)=44 S SSFIEN=MELIEN Q
17 .I $E(PS,3,4)=51 S SSFIEN=MELIEN Q
18 .I $E(PS,3,4)=60 S SSFIEN=MELIEN Q
19 .I PS=67632 S SSFIEN=MELIEN Q
20 ;
21 ;Hodgkin and Non-Hodgkin Lymphomas of All Sites
22 I $$LYMPHOMA^ONCFUNC(D0) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
23 ;
24 ;Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis, Scrotum
25 ;Kaposi Sarcoma of All Sites
26 I (MO=97003)!(MO=97013)!($E(MO,1,4)=9140) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
27 ;
28 ;Hematopoietic, Reticuloendothelial, Immunoproliferative, and
29 ;Myeloproliferative Neoplasms
30 I (MO'<97310)&(MO'>99899) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
31 ;
32 ;Retinoblastoma
33 I $E(MO,1,3)=951 S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
34 ;
35 ;Prostate
36 I PS=67619,+X>1,+X<11 D G ITEX
37 .I X'?3N D K X Q
38 ..I X?1N W !!," For ",X," enter 00",X
39 ..I X?2N W !!," For ",X," enter 0",X
40 ;
41 I '$D(^ONCO(164.52,SSFIEN,1,"B",X)) K X Q
42 S SSF=$O(^ONCO(164.52,SSFIEN,1,"B",X,0))
43 W " ",$P(^ONCO(164.52,SSFIEN,1,SSF,0),U,2)
44ITEX K PS,SSFIEN,SSF,MO,MELING Q
45 ;
46SSF6OT ;OUTPUT TRANSFORM
47 ;
48 S PS=$P($G(^ONCO(165.5,D0,2)),U,1)
49 Q:PS=""
50 S MO=$$HIST^ONCFUNC(D0)
51 ;
52 S SSFIEN=$S($D(^ONCO(164.52,"C",PS_"-6")):$O(^ONCO(164.52,"C",PS_"-6",0)),1:1)
53 ;
54 ;Malignant Melanoma of Skin, Vulva, Penis, Scrotum
55 I $$MELANOMA^ONCOU55(D0) D
56 .S MELIEN=$O(^ONCO(164.52,"B","LDH",0))
57 .I $E(PS,3,4)=44 S SSFIEN=MELIEN Q
58 .I $E(PS,3,4)=51 S SSFIEN=MELIEN Q
59 .I $E(PS,3,4)=60 S SSFIEN=MELIEN Q
60 .I PS=67632 S SSFIEN=MELIEN Q
61 ;
62 ;Hodgkin and Non-Hodgkin Lymphomas of All Sites
63 I $$LYMPHOMA^ONCFUNC(D0) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
64 ;
65 ;Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis, Scrotum
66 ;Kaposi Sarcoma of All Sites
67 I (MO=97003)!(MO=97013)!($E(MO,1,4)=9140) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
68 ;
69 ;Hematopoietic, Reticuloendothelial, Immunoproliferative, and
70 I (MO'<97310)&(MO'>99899) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
71 ;
72 ;Retinoblastoma
73 I $E(MO,1,3)=951 S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
74 ;
75 ;Prostate
76 I PS=67619,+Y>1,+Y<11 G OTEX
77 ;
78 S SSF=$O(^ONCO(164.52,SSFIEN,1,"B",Y,0)) I SSF="" G OTEX
79 S Y=$P($G(^ONCO(164.52,SSFIEN,1,SSF,0)),U,2)
80OTEX K PS,SSFIEN,SSF,MO Q
81 ;
82SSF6HP ;HELP
83 ;
84 S PS=$P($G(^ONCO(165.5,D0,2)),U,1)
85 Q:PS=""
86 S MO=$$HIST^ONCFUNC(D0)
87 ;
88 S SSFIEN=$S($D(^ONCO(164.52,"C",PS_"-6")):$O(^ONCO(164.52,"C",PS_"-6",0)),1:1)
89 ;
90 ;Malignant Melanoma of Skin, Vulva, Penis, Scrotum
91 I $$MELANOMA^ONCOU55(D0) D
92 .S MELIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
93 .I $E(PS,3,4)=44 S SSFIEN=MELIEN Q
94 .I $E(PS,3,4)=51 S SSFIEN=MELIEN Q
95 .I $E(PS,3,4)=60 S SSFIEN=MELIEN Q
96 .I PS=67632 S SSFIEN=MELIEN Q
97 ;
98 ;Hodgkin and Non-Hodgkin Lymphomas of All Sites
99 I $$LYMPHOMA^ONCFUNC(D0) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
100 ;
101 ;Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis, Scrotum
102 ;Kaposi Sarcoma of All Sites
103 I (MO=97003)!(MO=97013)!($E(MO,1,4)=9140) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
104 ;
105 ;Hematopoietic, Reticuloendothelial, Immunoproliferative, and
106 I (MO'<97310)&(MO'>99899) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
107 ;
108 ;Retinoblastoma
109 I $E(MO,1,3)=951 S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
110 ;
111 W !," SITE-SPECIFIC FACTOR 6 for " D
112 .I MO=97003 W "MYCOSIS FUNGOIDES of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
113 .I MO=97013 W "SEZARY SYNDROME of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
114 .I $E(MO,1,3)=951 W "RETINOBLASTOMA of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
115 .I $$MELANOMA^ONCOU55(D0),($E(PS,3,4)=44)!($E(PS,3,4)=51)!($E(PS,3,4)=60)!(PS=67632)!($E(PS,3,4)=69) W "MALIGNANT MELANOMA of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
116 .I $E(MO,1,4)=9140 W "KAPOSI SARCOMA of ALL SITES" Q
117 .I $$LYMPHOMA^ONCFUNC(D0) W "HODGKIN AND NON-HODGKIN LYMPHOMAS of ALL SITES" Q
118 .I (MO'<97310)&(MO'>99899) W $P(^ONCO(169.3,MO,0),U,1)," (",$P(^ONCO(169.3,MO,0),U,2),")" Q
119 .W $P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")"
120 W !," ",$P(^ONCO(164.52,SSFIEN,0),U,1)
121 ;S SSF=0 F S SSF=$O(^ONCO(164.52,SSFIEN,1,SSF)) Q:SSF'>0 D
122 ;.S TAB=6
123 ;.I ($P(^ONCO(164.52,SSFIEN,0),U,1)="GLEASON'S SCORE") S TAB=10
124 ;.W " ",$P(^ONCO(164.52,SSFIEN,1,SSF,0),U,1),?TAB,$P(^ONCO(164.52,SSFIEN,1,SSF,0),U,2),!
125 K PS,SSFIEN,SSF,MO Q
Note: See TracBrowser for help on using the repository browser.